logo

Fate Therapeutics Inc (FATE) Stock: Navigating Market Highs and Lows in 52 Weeks

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Fate Therapeutics Inc’s current trading price is -25.14% away from its 52-week high, while its distance from the 52-week low is 305.52%. The stock’s price range during this period has varied between $1.63 and $8.83. The company, active in the Healthcare sector, saw a trading volume of around 1.99 million for the day, considerably lower average daily volume of 2.92 million observed over the last three months.

Fate Therapeutics Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $8.83 on 03/07/24, and the lowest price during the same period was recorded at $1.63 on 10/30/23.

How Financial Performance Impacts Market Capitalization

Fate Therapeutics Inc (FATE) has experienced a quarterly rise of 116.01% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 655.98M and boasts a workforce of 181 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 4.61, with a change in price of +4.96. Similarly, Fate Therapeutics Inc recorded 2,495,252 in trading volume during the last 100 days, posting a change of +300.61%.

How FATE’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for FATE stands at 0.28. Similarly, the long-term debt-to-equity ratio is also 0.26.

FATE Stock Stochastic Average

As of today, the raw stochastic average of Fate Therapeutics Inc over the past 50 days is 53.07%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 0.00%. Additionally, the Stochastic %K and %D values for the company were 31.53% and 30.33%, respectively, over the past 20 days.

FATE Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a gain of 76.74%.However, over the last six months, we can see a weaker performance of 201.83%. Over the last 30 days, the price of FATE has leaped by -3.92%. And in the last five days, it has fallen by -11.75%.